Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial. - Rose AAN; Maxwell J; Rousselle E; Mukonoweshuro CL; Elkholi IE; Riaud M; Biondini M; Cianfarano E; Soria-Bretones I; Tobin C; McGuire M; Law RWY; et al. (Nature communications, 2026)